<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2014-09-23 17:42:54Pharmacology Fixed dose combination Organofluorides Cyclopropanes Non-nucleoside reverse transcriptase inhibitors Reverse-transcriptase inhibitor Antiretroviral drug Tenofovir Efavirenz Chemistry Organic chemistry Gilead Sciences |
Add to Reading List |
Indiana State Department of Health | DEPARTMENT OF BIOCHEMISTRY FRONTIERS PROFESSOR KENNETH JOHNSON Roger J. Williams Centennial Professor of Biochemistry, University of Texas, USA DATEDocID: 1pw8Q - View Document |
| Human Immunodeficiency Virus (HIV) is a potential precursor to Acquired Immune Deficiency Syndrome (AIDS), which commonly treated with a mixture of reverse transcriptase inhibitors (RTI) and protease inhibitors (PI). AdaDocID: 1pbRe - View Document |
| New Zealand Consumer Medicine Information Viramune Tablets and Oral Suspension NevirapineDocID: 1gvCL - View Document |
| Viramune Tablets Viramune Oral Suspension Nevirapine Consumer Medicine InformationDocID: 1gtrY - View Document |
| ANTIRETROVIRAL PRIORITIES OF THE MEDICINES PATENT POOLDocID: 1fNy0 - View Document |